Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.
about
An orthotopic lung tumor model for image-guided microirradiation in ratsImage-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectivesOptimal combination of antiangiogenic therapy for hepatocellular carcinomaAre three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?Oligometastasis and oligo-recurrence: more than a mirageRecent advances in multidisciplinary management of hepatocellular carcinomaReview and uses of stereotactic body radiation therapy for oligometastasesRole of stereotactic body radiation therapy for hepatocellular carcinomaStereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancerDevelopment of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panelEmergence of stereotactic body radiation therapy and its impact on current and future clinical practiceStereotactic Body Radiotherapy in the Management of Oligometastatic DiseaseModel-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicineAnniversary Paper: the role of medical physicists in developing stereotactic radiosurgery.Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients.Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.Strategies to tackle the challenges of external beam radiotherapy for liver tumorsSafety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases.Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.Target localization using scanner-acquired SPECT data.Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapyInterfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression.Robotic stereotactic body radiation therapy for liver-limited malignant tumorsQuantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.Extracranial stereotactic radiation delivery: expansion of technology beyond the brain.Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography.Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.Early experience of helical tomotherapy for hepatobiliary radiotherapyStereotactic radiation therapy for liver metastases: factors affecting local control and survivalDifferences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient SelectionCT Imaging Findings after Stereotactic Radiotherapy for Liver Tumors.Multicentre results of stereotactic body radiotherapy for secondary liver tumours.Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma.Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function.Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.Cyberknife treatment for advanced or terminal stage hepatocellular carcinomaPrognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy.
P2860
Q24595548-8571AB37-F67C-411E-BD65-C760001CF45CQ26738434-4FD2A03B-D2D3-4BDC-A478-E25B6ACFF852Q26799458-EAF23FDB-C1CB-44DB-B38A-1B32CC952FCAQ26823670-9E4F6911-FAC0-4739-800A-A4466E18D5BEQ26828767-A7694BC9-959C-4367-A943-3AEE8F363D11Q26863748-EA0AAED7-6FDD-4728-AA6A-32CC9302933FQ26864247-740D19E1-EE8B-428A-ABA1-AA2A271A8D04Q26864969-64A68161-CA34-40B6-A631-FA347FEA7913Q26866335-59E6880E-CE85-4585-AC0E-978794E2B8D9Q27014926-7E269F03-523F-431C-AEC0-9CE068175CAEQ27015651-5F634043-28D9-4A3D-9C51-6083A5981423Q28071733-00197264-6032-4710-962C-A8F7E90F1BC7Q28087569-1C95986E-8623-4340-80FB-517E64FF314AQ30447048-012204A0-33B2-44B0-9EA4-9523E046484FQ33645887-452E5F65-4551-4C86-9AE8-BE8F53233EC2Q33682891-E9C8DF1B-CB73-4B82-84A8-92D6A4A8528BQ33706721-E8319575-6573-4570-8581-A7CDF5B5F12DQ33818776-0CC886A0-4B54-407D-8046-F289535E34DFQ33823590-F1CDB4F3-8110-4569-8276-9B2F12DF17ABQ33922093-F14D1F46-9CB4-45A7-B5FC-D7E8EFA3B37DQ34268528-796812E0-8B1A-4395-B3EC-7EEC9D8DEF12Q34461833-654F82EA-C937-4049-8F21-D5A8309F4B47Q34567594-F11C9245-D419-4200-B612-38D06E634D49Q34791775-D85BC3DD-65CF-4B9A-849E-C8AEC8E84F71Q34957175-C8FFE21D-C8ED-4E65-BC53-A9731245F0D6Q35101606-F96B918A-237E-4B0B-968B-21536AA7358BQ35108961-CB1C7496-41DC-4519-8D81-05DDDC972A26Q35207748-40C6FD95-4B61-448A-B429-5C72F29B1F7CQ35545055-6661879B-BB7C-4D77-9C5D-65563674E35CQ35731820-EE6ED6FA-915D-4A49-9E34-761B20C35DD2Q35782954-1F359048-B31C-4203-9D08-1DE80D69D35EQ35843910-14DAC1F5-8257-4B0B-BBDF-AF28BDF82373Q35854741-D2A475E6-4417-4CA5-88FA-DA8F60395276Q36190116-7C753DD6-26B9-4A29-A31D-6E6FF82A189BQ36298915-6DED7DCE-2C1B-4443-B4FC-4D82707D206EQ36299709-72603BF2-5DD5-4517-80FD-7FCC44261CE4Q36324498-F63B1A22-5D69-447E-A99B-C08CDE6E9D4DQ36360066-C0EAFE54-9163-4482-B54F-3CFFC2E4F024Q36360832-95628375-EC00-44DC-9CC5-E980D5FAF6B5Q36388360-4F8B97C1-1947-4121-B661-02D28A203926
P2860
Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Stereotactic single-dose radia ...... results of a phase I/II trial.
@en
Stereotactic single-dose radia ...... results of a phase I/II trial.
@nl
type
label
Stereotactic single-dose radia ...... results of a phase I/II trial.
@en
Stereotactic single-dose radia ...... results of a phase I/II trial.
@nl
prefLabel
Stereotactic single-dose radia ...... results of a phase I/II trial.
@en
Stereotactic single-dose radia ...... results of a phase I/II trial.
@nl
P2093
P921
P1476
Stereotactic single-dose radia ...... results of a phase I/II trial.
@en
P2093
K K Herfarth
M F Wannenmacher
M L Bahner
W Schlegel
P304
P356
10.1200/JCO.2001.19.1.164
P407
P577
2001-01-01T00:00:00Z